Articles with public access mandates - Andreas von DeimlingLearn more
OverallNIHDFGHelmholtzBMBFBrain Tumour Charity, UKCancer Research UKNIHRMRCEuropean CommissionCIHRKWFSNSFSCFDoDFNRNHMRCGenome CanadaCCSGovernment of SpainSCLGovernment of ItalyVAFWFWellcomeFWOFRQSCPRITAmerican Brain Tumor AssociationOICRNSFDOEUSDAGBMFNSERCNSFCBanking Foundation "la Caixa"INSERMMTAOTKAWHORCNNCNV Foundation, USAAIRC Foundation for Cancer Research in ItalyChildren's Tumor Foundation, USAHFSPSusan G. Komen
Not available anywhere: 37
Brain tumour cells interconnect to a functional and resistant network
M Osswald, E Jung, F Sahm, G Solecki, V Venkataramani, J Blaes, S Weil, ...
Nature 528 (7580), 93-98, 2015
Mandates: German Research Foundation
Actively personalized vaccination trial for newly diagnosed glioblastoma
N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ...
Nature 565 (7738), 240-245, 2019
Mandates: Cancer Research UK, UK Medical Research Council
A vaccine targeting mutant IDH1 induces antitumour immunity
T Schumacher, L Bunse, S Pusch, F Sahm, B Wiestler, J Quandt, O Menn, ...
Nature 512 (7514), 324-327, 2014
Mandates: US National Institutes of Health, German Research Foundation
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
F Sahm, D Schrimpf, DTW Jones, J Meyer, A Kratz, D Reuss, D Capper, ...
Acta neuropathologica 131, 903-910, 2016
Mandates: Helmholtz Association
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
A Korshunov, D Capper, D Reuss, D Schrimpf, M Ryzhova, V Hovestadt, ...
Acta neuropathologica 131, 137-146, 2016
Mandates: Cancer Research UK, Wellcome Trust, Brain Tumour Charity, UK
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
S Pusch, S Krausert, V Fischer, J Balss, M Ott, D Schrimpf, D Capper, ...
Acta neuropathologica 133, 629-644, 2017
Mandates: Helmholtz Association, Federal Ministry of Education and Research, Germany
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma
K Ochs, F Sahm, CA Opitz, TV Lanz, I Oezen, PO Couraud, ...
Journal of neuroimmunology 265 (1-2), 106-116, 2013
Mandates: German Research Foundation
Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR
H Bösmüller, A Fischer, DL Pham, T Fehm, D Capper, A Von Deimling, ...
Human pathology 44 (3), 329-335, 2013
Mandates: US National Institutes of Health
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
A Korshunov, M Remke, M Kool, T Hielscher, PA Northcott, D Williamson, ...
Acta neuropathologica 123, 515-527, 2012
Mandates: Cancer Research UK
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain
C Geisenberger, A Mock, R Warta, C Rapp, C Schwager, A Korshunov, ...
Acta neuropathologica 130, 419-434, 2015
Mandates: US National Institutes of Health
Identification of novel oligodendroglioma‐associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray‐based expression profiling
B Tews, J Felsberg, C Hartmann, A Kunitz, M Hahn, G Toedt, K Neben, ...
International journal of cancer 119 (4), 792-800, 2006
Mandates: German Research Foundation
Nonmetastatic medulloblastoma of early childhood: results from the prospective clinical trial HIT-2000 and an extended validation cohort
M Mynarek, K von Hoff, T Pietsch, H Ottensmeier, M Warmuth-Metz, ...
Journal of clinical oncology 38 (18), 2028-2040, 2020
Mandates: Helmholtz Association
Interlaboratory comparison of IDH mutation detection
MJ Van Den Bent, C Hartmann, M Preusser, T Ströbel, HJ Dubbink, ...
Journal of neuro-oncology 112, 173-178, 2013
Mandates: US National Institutes of Health
Suppression of TDO‐mediated tryptophan catabolism in glioblastoma cells by a steroid‐responsive FKBP52‐dependent pathway
M Ott, UM Litzenburger, KJ Rauschenbach, L Bunse, K Ochs, F Sahm, ...
Glia 63 (1), 78-90, 2015
Mandates: German Research Foundation
Infratentorial IDH-mutant astrocytoma is a distinct subtype
R Banan, D Stichel, A Bleck, B Hong, U Lehmann, A Suwala, A Reinhardt, ...
Acta neuropathologica 140, 569-581, 2020
Mandates: German Research Foundation
Tryptophan‐2, 3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4
K Ochs, M Ott, KJ Rauschenbach, K Deumelandt, F Sahm, CA Opitz, ...
Journal of neurochemistry 136 (6), 1142-1154, 2016
Mandates: German Research Foundation, Helmholtz Association
Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib
A Berberich, T Kessler, CM Thomé, S Pusch, T Hielscher, F Sahm, ...
Clinical Cancer Research 25 (1), 253-265, 2019
Mandates: Helmholtz Association
BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts
L Schweizer, D Capper, A Hölsken, R Fahlbusch, J Flitsch, M Buchfelder, ...
Neuropathology and Applied Neurobiology 41 (6), 733-742, 2015
Mandates: German Research Foundation
BRAF V 600 E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma
C Koelsche, F Sahm, W Paulus, M Mittelbronn, F Giangaspero, ...
Neuropathology and Applied Neurobiology 40 (3), 337-344, 2014
Mandates: German Research Foundation
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
C Thomas, A Wefers, S Bens, K Nemes, A Agaimy, F Oyen, ...
Acta neuropathologica 139, 277-286, 2020
Mandates: German Research Foundation
Publication and funding information is determined automatically by a computer program